We demonstrate that FLRT2 elevates ACSL4 expression and subsequently facilitates lipid peroxidation and ferroptosis, thereby inhibiting the malignant phenotype of human bladder cancer cells. Here, ACSL4 is linked to urinary bladder cancer.